my account  log out
 

Alpelisib

Create: 09/23/2019
Expired Date:never
Category: Chemical
Message:Alpelisib, also known as BLY719, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BYL719 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.https://www.bocsci.com/alpelisib-cas-1217486-61-7-item-457654.html
City:New York[US] 
Location:
 
Sep 23 2019Y-27632 2HCl237
Sep 23 2019BMS-911543254
Sep 23 2019JQ-1 cas 1268524-70-4241
Sep 23 2019Alectinib235
Sep 23 2019Tubastatin A243
Sep 23 2019FLLL32241
Sep 23 2019Thiazovivin245
Sep 23 2019Alpelisib247
Sep 23 2019Ribociclib223
Sep 23 2019Midostaurin223

return back

Copyright © toextrade Inc. All rights reserved. Contact us